Fenspiride hydrochloride

CAS No. 5053-08-7

Fenspiride hydrochloride ( Decaspiride )

Catalog No. M14723 CAS No. 5053-08-7

Fenspiride is an oxazolidinone spiro compound used as a drug in the treatment of certain respiratory diseases.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 41 In Stock
100MG 60 In Stock
200MG 88 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fenspiride hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Fenspiride is an oxazolidinone spiro compound used as a drug in the treatment of certain respiratory diseases.
  • Description
    Fenspiride is an oxazolidinone spiro compound used as a drug in the treatment of certain respiratory diseases. It is approved for use in Russia for the treatment of acute and chronic inflammatory diseases of ENT organs and the respiratory tract (like rhinopharyngitis, laryngitis, tracheobronchitis, otitis and sinusitis), as well as for maintenance treatment of asthma.
  • Synonyms
    Decaspiride
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE3; PDE4
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    5053-08-7
  • Formula Weight
    296.79
  • Molecular Formula
    C15H20N2O2·HCl
  • Purity
    >98%(HPLC)
  • Solubility
    Water: 59 mg/mL (198.79 mM); DMSO: 9 mg/mL (30.32 mM)
  • SMILES
    C1CN(CCC12CNC(=O)O2)CCC3=CC=CC=C3.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cortijo J, et al. Eur J Pharmacol, 1998, 341(1), 79-86.
molnova catalog
related products
  • YM976

    YM976 is an orally active PDE4 inhibitor (IC50:2.2 nM).

  • Apremilast

    Apremilast (CC-10004) is a potent, orally active PDE4 inhibitor with IC50 of 74 nM, inhibits TNF-α production in LPS-stimulated hPBMCs with IC50 of 77 nM.

  • ITI214 free base

    ITI-214 is a potent, selective phosphodiesterase 1 (PDE1) inhibitor with Ki of 58 pM.